Literature DB >> 29182249

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

M Mercè Fernández‑Balsells1, Lidia Sojo-Vega2, Wifredo Ricart-Engel3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29182249     DOI： 10.1056/NEJMc1712572

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of dapagliflozin in the treatment of chronic heart failure: A protocol for systematic review and meta-analysis.

Authors:  Xueyan Dong; Lili Ren; Yueli Liu; Xuewei Yin; Siyuan Cui; Wulin Gao; Liming Yu
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.